The therapeutic interventions encompassed the administration of aspirin [157,158,159] antagonist of the platelet receptor P2Y12 [157,158,159,160] and Tifacogin (recombinant tissue factor pathway inhibitor) [161] in patients experiencing severe sepsis, with the objective of evaluating their efficacy and safety. Here, F3 is linked to Sepsis.